OBJECTIVE: The purpose of this study was to assess the effectiveness of instituting a comprehensive protocol for the treatment of maternal hemorrhage. STUDY DESIGN: The protocol was separated into 4 stages, designated 0-3, based on the degree of blood loss and the patient response to interventions. Key components included admission risk assessment, measurement of blood loss, early but limited use of uterotonic agents, early presence of obstetrical and anesthesia staff, and transfusion with fixed ratios of blood products. Data were collected retrospectively and prospectively relative to the start of the protocol. RESULTS: We noted a significant shift toward resolution of maternal bleeding at an earlier stage (P < .01), use of fewer blood products (P < .01), and a 64% reduction in the rate of disseminated intravascular coagulation. In addition, there were significant improvements in staff and physician perceptions of patient safety (P < .01). CONCLUSION: Comprehensive maternal hemorrhage treatment protocols improve patient safety and reduce utilization of blood products.
OBJECTIVE: The purpose of this study was to assess the effectiveness of instituting a comprehensive protocol for the treatment of maternal hemorrhage. STUDY DESIGN: The protocol was separated into 4 stages, designated 0-3, based on the degree of blood loss and the patient response to interventions. Key components included admission risk assessment, measurement of blood loss, early but limited use of uterotonic agents, early presence of obstetrical and anesthesia staff, and transfusion with fixed ratios of blood products. Data were collected retrospectively and prospectively relative to the start of the protocol. RESULTS: We noted a significant shift toward resolution of maternal bleeding at an earlier stage (P < .01), use of fewer blood products (P < .01), and a 64% reduction in the rate of disseminated intravascular coagulation. In addition, there were significant improvements in staff and physician perceptions of patient safety (P < .01). CONCLUSION: Comprehensive maternal hemorrhage treatment protocols improve patient safety and reduce utilization of blood products.
Authors: Jill M Mhyre; Alexander Shilkrut; Elena V Kuklina; William M Callaghan; Andreea A Creanga; Sari Kaminsky; Brian T Bateman Journal: Obstet Gynecol Date: 2013-12 Impact factor: 7.661
Authors: D Schlembach; M G Mörtl; T Girard; W Arzt; E Beinder; C Brezinka; K Chalubinski; D Fries; W Gogarten; B-J Hackelöer; H Helmer; W Henrich; I Hösli; P Husslein; F Kainer; U Lang; G Pfanner; W Rath; E Schleussner; H Steiner; D Surbek; R Zimmermann Journal: Anaesthesist Date: 2014-03 Impact factor: 1.041
Authors: Alexander J Butwick; Brendan Carvalho; Yair J Blumenfeld; Yasser Y El-Sayed; Lorene M Nelson; Brian T Bateman Journal: Am J Obstet Gynecol Date: 2015-01-09 Impact factor: 8.661
Authors: Sarah F Bell; Rachel E Collis; Philip Pallmann; Christopher Bailey; Kathryn James; Miriam John; Kevin Kelly; Thomas Kitchen; Cerys Scarr; Adam Watkins; Tracey Edey; Elinore Macgillivray; Kathryn Greaves; Ingrid Volikas; James Tozer; Niladri Sengupta; Iolo Roberts; Claire Francis; Peter W Collins Journal: BMC Pregnancy Childbirth Date: 2021-05-15 Impact factor: 3.007
Authors: Dietmar Schlembach; Hanns Helmer; Wolfgang Henrich; Christian von Heymann; Franz Kainer; Wolfgang Korte; Maritta Kühnert; Heiko Lier; Holger Maul; Werner Rath; Susanne Steppat; Daniel Surbek; Jürgen Wacker Journal: Geburtshilfe Frauenheilkd Date: 2018-04-26 Impact factor: 2.915